Treatment of tinea capitis: beyond griseofulvin - 07/09/11
Abstract |
Tinea capitis is a common pediatric scalp infection caused by dermatophytes. Topical therapy alone is ineffective, so oral griseofulvin has traditionally been the standard treatment. The new antimycotic agents itraconazole, terbinafine, and fluconazole represent effective treatment alternatives that have fewer problems with tolerability and adverse effects. More comparative studies are needed to determine the optimal treatment with these agents and adjuvant therapies such as antifungal shampoos, topical antimycotic agents, and cortico-steroids. (J Am Acad Dermatol 1999;40:S27-30.)
Le texte complet de cet article est disponible en PDF.Plan
 | This work was supported by a research grant from Pfizer Inc. The author has received research grants from Novartis, Janssen, Glaxo, and Westwood, and has served as a consultant for Mylan, Janssen, and Novartis. |
| Reprint requests: Boni Elewski, MD, University Suburban Health Center, 1611 South Green Road, Suite 056, Cleveland, OH 44121. |
 | 0190-9622/99/$8.00 + 0 16/0/98109 |
Vol 40 - N° 6S
P. S27-S30 - juin 1999 Retour au numéro
Article précédent
- Onychomycosis: therapeutic update
- Richard K. Scher
- Oral therapy of common superficial fungal infections of the skin
- Jack L. Lesher
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?